Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
9.47
+0.51 (5.69%)
Feb 18, 2026, 4:00 PM EST - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $7.95 million as of February 19, 2026. Its market cap has increased by 235.89% in one year.
Market Cap
7.95M
Enterprise Value
5.01M
1-Year Change
235.89%
Ranking
Category
Stock Price
$9.47
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $7.95M, a decrease of -91.82%. That is a compound annual growth rate of -44.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 7.52M | -37.91% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 8.39M |
| NuCana | 8.32M |
| Aspire Biopharma Holdings | 7.99M |
| TransCode Therapeutics | 7.94M |
| Kiora Pharmaceuticals | 7.41M |
| Addex Therapeutics | 7.34M |
| Aptevo Therapeutics | 7.13M |
| Moolec Science | 6.96M |